Lysine

Lysine

SCHEMBL6301386

NCCCC[C@H](N)C(=O)O.O=C(O)CN[C@@H](CS)C(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 known ✓ P23219 2/20 0.47
GSR P00390 2/20 0.59
GSTK1 Q9Y2Q3 1/20 0.47
CPB2 Q96IY4 2/20 0.45
FOLH1 Q04609 1/20 0.43
RNPEP Q9H4A4 1/20 0.41
ARG2 P78540 4/20 0.39
ARG1 P05089 3/20 0.39
SLC7A11 Q9UPY5 1/20 0.39
GRM8 O00222 1/20 0.37
GRM6 O15303 1/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
CYP1A2 P05177 1/20 0.37
GRIK1 P39086 1/20 0.37
GRM5 P41594 1/20 0.37
GRIA1 P42261 1/20 0.37
GRIA2 P42262 1/20 0.37
GRIA3 P42263 1/20 0.37
SLC1A3 P43003 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL3677532 1.00 GSR (0.59) GSRPTGS1GSTK1CPB2FOLH1
Lysine SCHEMBL27944317 1.00 GSR (0.59) GSRPTGS1GSTK1CPB2FOLH1
Lysine SCHEMBL1042959 1.00 GSR (0.59) GSRPTGS1GSTK1CPB2FOLH1
Lysine SCHEMBL6301384 1.00 GSR (0.59) GSRPTGS1GSTK1CPB2FOLH1
Lysine SCHEMBL9574568 0.99 GSR (0.57) GSRPTGS1GSTK1CPB2FOLH1
Lysine SCHEMBL9118672 0.87 GSR (0.61) GSRPTGS1GSTK1CPB2FOLH1
Cysteine SCHEMBL28399079 0.82 PTGS1 (0.59) GSRPTGS1GSTK1FOLH1SLC7A11
SCHEMBL4158587 0.82 FOLH1 (0.50) GSRPTGS1GSTK1CPB2FOLH1
SCHEMBL31448267 0.81 GSR (0.50) GSRARG2ARG1GRM8GRM6
SCHEMBL43620 0.81 FOLH1 (0.57) GSRCPB2FOLH1RNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120201990-A Personal care compositions 联合利华知识产权控股有限公司 2025-06-24 CN claimed
CN-118660690-A Personal care or pharmaceutical compositions 联合利华知识产权控股有限公司 2024-09-17 CN claimed
CN-118541138-A Personal care compositions 联合利华知识产权控股有限公司 2024-08-23 CN claimed
CN-118488823-A Personal care compositions 联合利华知识产权控股有限公司 2024-08-13 CN claimed
CN-117357420-A Hair care composition, hair care essence and preparation method thereof 拉芳家化股份有限公司 2024-01-09 CN claimed
CN-113546000-B High-stability whitening skin care product and preparation method thereof 北京美丽臻颜化妆品有限公司 2022-07-12 CN claimed
WO-2014111957-A1 NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS SATYAM APPARAO (IN) 2014-07-24 WO claimed
WO-2025133372-A1 USE OF CYSTEINE PRECURSOR COMPOUND UNILEVER IP HOLDINGS B.V. (NL) 2025-06-26 WO disclosed
CN-120201990-A Personal care compositions 联合利华知识产权控股有限公司 2025-06-24 CN disclosed
CN-118660690-A Personal care or pharmaceutical compositions 联合利华知识产权控股有限公司 2024-09-17 CN disclosed
CN-118541138-A Personal care compositions 联合利华知识产权控股有限公司 2024-08-23 CN disclosed
CN-118488823-A Personal care compositions 联合利华知识产权控股有限公司 2024-08-13 CN disclosed
CN-117357420-A Hair care composition, hair care essence and preparation method thereof 拉芳家化股份有限公司 2024-01-09 CN disclosed
CN-113546000-B High-stability whitening skin care product and preparation method thereof 北京美丽臻颜化妆品有限公司 2022-07-12 CN disclosed
EP-2654665-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) 2013-10-30 EP disclosed
WO-2012083906-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) 2012-06-28 WO disclosed
US-6893631-B1 Shaving soap and aftershave gel and methods of use thereof MITCHELL & SONS, LLC (US) 2005-05-17 US disclosed